NPI: 1457307936 · MEMPHIS, TN 38116 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 05/26/2006
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 05/26/2006 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 12,698 | $363K |
| 2019 | 14,870 | $513K |
| 2020 | 21,845 | $546K |
| 2021 | 14,553 | $367K |
| 2022 | 10,249 | $335K |
| 2023 | 5,342 | $307K |
| 2024 | 2,277 | $128K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 39,110 | 2,950 | $2.52M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 21,044 | 1,139 | $36K |
| J1270 | Injection, doxercalciferol, 1 mcg | 10,929 | 919 | $4K |
| A4657 | Syringe, with or without needle, each | 3,026 | 1,312 | $2K |
| J1756 | Injection, iron sucrose, 1 mg | 2,818 | 654 | $726.00 |
| 0012A | 14 | 13 | $80.00 | |
| 0011A | 14 | 14 | $80.00 | |
| 82728 | 800 | 759 | $0.00 | |
| 83550 | 745 | 713 | $0.00 | |
| 82746 | 28 | 26 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 98 | 88 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 207 | 125 | $0.00 |
| 90674 | 43 | 39 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 12 | 12 | $0.00 |
| 83970 | 871 | 806 | $0.00 | |
| 85048 | 595 | 567 | $0.00 | |
| 85041 | 584 | 556 | $0.00 | |
| 82108 | 34 | 30 | $0.00 | |
| 83540 | 809 | 765 | $0.00 | |
| 85045 | 53 | 51 | $0.00 |